Dennis Fenton

Dennis Fenton, Ph.D. has served as a member of our Board since June 2006. Dr. Fenton is the owner and CEO of Fenton and Associates (biotechnology consulting). Prior to his retirement, Dr. Fenton most recently served as Executive Vice President of Operations at Amgen from 2000 to 2008, where he was responsible for worldwide operations, manufacturing, process development and quality. Starting in 1982, Dr. Fenton held numerous executive leadership roles in operations and sales and marketing at Amgen. Dr. Fenton also serves on the board of directors of Hospira, Inc., Dendreon Corporation and XenoPort, Inc. and the board of trustees of the Keck Graduate Institute. Dr. Fenton was a director of the Genzyme Corporation from 2010 to 2011. Dr. Fenton received a B.S. in Biology from Manhattan College and a Ph.D. in Microbiology from Rutgers University.